Michael Dunn
Presidente presso CALCIMEDICA, INC.
Patrimonio netto: - $ in data 31/05/2024
Profilo
Michael J.
Dunn is currently the Director at Arisan Therapeutics, Inc. He is also the President & Chief Operating Officer at CalciMedica, Inc. (US) and CalciMedica, Inc. In the past, he has worked as the Director at Aegea Biotechnologies, Inc. from 2012 to 2017.
He has also held positions such as Vice President-Business Development at Sibia Neurosciences, Inc., Chief Business Officer & Vice President at Monogram Biosciences, Inc., SVP-Corporate Development & Business Development at Biocept, Inc. from 2011 to 2013, Chief Business Officer & Vice President at ACLARA Biosciences, Inc. from 2003 to 2004, Vice President-Business Development at Aurora Biosciences Corp.
from 1998 to 2002, and Chief Business Officer & Vice President at ActivX Biosciences, Inc. from 2002 to 2003.
Mr. Dunn completed his undergraduate degree at The University of Chicago and holds an MBA from the University of San Diego.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
CALCIMEDICA, INC.
-.--% | 28/03/2024 | 0 ( -.--% ) | - $ | 31/05/2024 |
Posizioni attive di Michael Dunn
| Società | Posizione | Inizio |
|---|---|---|
| CALCIMEDICA, INC. | Presidente | 01/01/2014 |
CalciMedica, Inc. (US)
 CalciMedica, Inc. (US) BiotechnologyHealth Technology CalciMedica, Inc. is a holding company, which engages in drug development. It discovers and develops novel small molecule drugs for the treatment of inflammatory and autoimmune disorders and organ transplant rejection. The company was founded by Gonul Velicelebi, Kenneth Stauderman, Anjana Rao, Patrick Hogan, Stefan Feske, Michael Harpold, Tom Reed, and Jack Roos in December 2006 and is headquartered in La Jolla, CA. | Presidente | 20/08/2013 |
Arisan Therapeutics, Inc.
 Arisan Therapeutics, Inc. BiotechnologyHealth Technology Arisan Therapeutics, Inc. develops novel therapeutics for the treatment of neglected and emerging infectious diseases. The private company is based in San Diego, CA. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Michael Dunn
| Società | Posizione | Fine |
|---|---|---|
Aegea Biotechnologies, Inc.
 Aegea Biotechnologies, Inc. Medical/Nursing ServicesHealth Services Aegea Biotechnologies, Inc. is a biotechnology company located in an undisclosed location. Aegea has been granted 11 US patents and 34 foreign equivalents worldwide. The American company's primary focus is on nucleic acid technology innovations, including molecular diagnostic assays, qPCR technologies, sequencing methods, and rapid point-of-care COVID-19 testing. The private company has complementary collaborations with Biocept and Tauriga Sciences for developing and commercializing its COVID-19 tests. The company was founded by Lyle J. Arnold, who has been the CEO since incorporation. | Direttore/Membro del Consiglio | 01/01/2017 |
| BIOCEPT, INC. | Corporate Officer/Principal | - |
ACLARA Biosciences, Inc.
 ACLARA Biosciences, Inc. Medical SpecialtiesHealth Technology ACLARA Biosciences, Inc. discovers, develops and markets innovative products to guide and improve treatment of serious viral, immunologic, and oncologic diseases. | Corporate Officer/Principal | 01/12/2004 |
ActivX Biosciences, Inc.
 ActivX Biosciences, Inc. Pharmaceuticals: MajorHealth Technology ActivX Biosciences, Inc. develops pharmaceutical products. It discovers and develops small molecule drugs for major unmet medical needs. The company was founded in 2000 and is located in La Jolla, CA | Corporate Officer/Principal | 01/04/2003 |
Aurora Biosciences Corp.
 Aurora Biosciences Corp. BiotechnologyHealth Technology Aurora Biosciences Corp. designs and develops proprietary drug discovery systems, services and technologies to the discovery of new medicine. It develops a proprietary ultra-high throughput screening platform that uniquely integrates innovative fluorescence chemistry, molecular biology, miniaturization, automation, and informatics. The company also provides assay development and screening services. Aurora was founded in 1995 and is located in San Diego, CA. | Corporate Officer/Principal | 01/03/2002 |
Formazione di Michael Dunn
| The University of Chicago | Undergraduate Degree |
| University of San Diego | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| BIOCEPT, INC. | Health Technology |
| CALCIMEDICA, INC. | Health Technology |
| Aziende private | 8 |
|---|---|
| Sibia Neurosciences, Inc. | Health Technology |
Aurora Biosciences Corp.
Aurora Biosciences Corp. BiotechnologyHealth Technology Aurora Biosciences Corp. designs and develops proprietary drug discovery systems, services and technologies to the discovery of new medicine. It develops a proprietary ultra-high throughput screening platform that uniquely integrates innovative fluorescence chemistry, molecular biology, miniaturization, automation, and informatics. The company also provides assay development and screening services. Aurora was founded in 1995 and is located in San Diego, CA. | Health Technology |
ACLARA Biosciences, Inc.
ACLARA Biosciences, Inc. Medical SpecialtiesHealth Technology ACLARA Biosciences, Inc. discovers, develops and markets innovative products to guide and improve treatment of serious viral, immunologic, and oncologic diseases. | Health Technology |
Monogram Biosciences, Inc.
 Monogram Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Monogram Biosciences, Inc. develops and commercializes diagnostic products for the treatment of human immunodeficiency virus (HIV) infection, hepatitis C virus (HCV) infection, and other viral illnesses, as well as cancer and other diseases. It offers HIV tests, including genotypic, phenotypic, tropism, and combined phenotype and genotype assays, suppression management and viral load testing, HCV assays and oncology tests. The company was founded in 1995 and is headquartered in South San Francisco, CA. | Commercial Services |
CalciMedica, Inc. (US)
CalciMedica, Inc. (US) BiotechnologyHealth Technology CalciMedica, Inc. is a holding company, which engages in drug development. It discovers and develops novel small molecule drugs for the treatment of inflammatory and autoimmune disorders and organ transplant rejection. The company was founded by Gonul Velicelebi, Kenneth Stauderman, Anjana Rao, Patrick Hogan, Stefan Feske, Michael Harpold, Tom Reed, and Jack Roos in December 2006 and is headquartered in La Jolla, CA. | Health Technology |
Arisan Therapeutics, Inc.
Arisan Therapeutics, Inc. BiotechnologyHealth Technology Arisan Therapeutics, Inc. develops novel therapeutics for the treatment of neglected and emerging infectious diseases. The private company is based in San Diego, CA. | Health Technology |
ActivX Biosciences, Inc.
ActivX Biosciences, Inc. Pharmaceuticals: MajorHealth Technology ActivX Biosciences, Inc. develops pharmaceutical products. It discovers and develops small molecule drugs for major unmet medical needs. The company was founded in 2000 and is located in La Jolla, CA | Health Technology |
Aegea Biotechnologies, Inc.
Aegea Biotechnologies, Inc. Medical/Nursing ServicesHealth Services Aegea Biotechnologies, Inc. is a biotechnology company located in an undisclosed location. Aegea has been granted 11 US patents and 34 foreign equivalents worldwide. The American company's primary focus is on nucleic acid technology innovations, including molecular diagnostic assays, qPCR technologies, sequencing methods, and rapid point-of-care COVID-19 testing. The private company has complementary collaborations with Biocept and Tauriga Sciences for developing and commercializing its COVID-19 tests. The company was founded by Lyle J. Arnold, who has been the CEO since incorporation. | Health Services |
- Borsa valori
- Insiders
- Michael Dunn
